J & J Vision launches Tecnis Eyhance IOL in EU

Johnson & Johnson (NYSE:JNJ) Vision said today that it launched its Tecnis Eyhance intraocular lens intended to treat cataracts in Europe. The newly launched next-gen IOL, which has already received CE Mark clearance in the European Union, is designed to provide high-quality vision at both immediate and far distances, which the company touted as “an important first for the monofocal IOL category.” The Tecnis Eyhance IOL is designed to provide improved intermediate vision when compared with standard aspheric monofocal IOLs, as well as 20/20 distance vision. J&J Vision said that patient-reported outcomes indicated that the Tecnis Eyhance IOL enabled improvements in physical tasks including walking on uneven surfaces and improved engagement in personal activities and hobbies. “Today, patients with cataracts are forced to make a trade-off decision on their vision when selecting a monofocal intraocular lens. They can have corrected vision at a distance, but require glasses for near and intermediate vision activities, which refers to everything at arm’s length such as computer work or looking at a car speedometer. Tecnis Eyhance IOL offers high quality intermediate as well as distance vision, which is an important advancement to allow patients greater ease in certain activities in their day-to-day lives,”  Dr. Oliver Findl of Hanusch Hospital Vienna said in a prepared statement. The company said it is launching the device initially in the UK...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Optical/Ophthalmic johnsonandjohnson Source Type: news